672323-07-8

Basic information

• Product Name: ethyl 3-(2,3-dichlorophenyl)-3-oxopropanoate
• Synonyms: ethyl 3-(2,3-dichlorophenyl)-3-oxopropanoate
• CAS NO: 672323-07-8
• Molecular Formula: C₁₁H₁₀Cl₂O₃
• Molecular Weight: 261.1013
• Mol File: 672323-07-8.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: ethyl 3-(2,3-dichlorophenyl)-3-oxopropanoate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 3-(2,3-dichlorophenyl)-3-oxopropanoate(672323-07-8)
• EPA Substance Registry System: ethyl 3-(2,3-dichlorophenyl)-3-oxopropanoate(672323-07-8)

Safety Data

• Hazardous Substances Data: 672323-07-8(Hazardous Substances Data)

Upstream product

• 2905-60-4 2,3-dichlorobenzoyl chloride 
• 141-78-6 ethyl acetate 

Relevant articles and documents

PYRAZOLONE DERIVATIVES AS NITROXYL DONORS

The disclosed subject matter provides pyrazolone derivative compounds, pharmaceutical compositions comprising such compounds, kits comprising such compounds, and methods of using such compounds or pharmaceutical compositions. In particular, the disclosed subject matter provides methods of using such compounds or pharmaceutical compositions for treating heart failure.

PYRAZOLOPYRIMIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS

In its many embodiments, the present invention provides a novel class of pyrazolo[1,5-a]pyrimidine compounds as inhibitors of cyclin dependent kinases, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the CDKs using such compounds or pharmaceutical compositions.

PYRAZOLOPYRIMIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS

In its many embodiments, the present invention provides a novel class of pyrazolo[1,5-a]pyrimidine compounds as inhibitors of cyclin dependent kinases, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the CDKs using such compounds or pharmaceutical compositions.

PYRAZOLOPYRIMIDINES AS CYCLIN-DEPENDENT KINASE INHIBITORS

In its many embodiments, the present invention provides a novel class of pyrazolo[1,5-a]pyrimidine compounds as inhibitors of cyclin dependent kinases, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the CDKs using such compounds or pharmaceutical compositions.